BR9508031A - Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do composto - Google Patents
Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do compostoInfo
- Publication number
- BR9508031A BR9508031A BR9508031A BR9508031A BR9508031A BR 9508031 A BR9508031 A BR 9508031A BR 9508031 A BR9508031 A BR 9508031A BR 9508031 A BR9508031 A BR 9508031A BR 9508031 A BR9508031 A BR 9508031A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- human
- antiviral
- prophylactic
- veterinary composition
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000000069 prophylactic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000000412 dendrimer Substances 0.000 abstract 2
- 229920000736 dendritic polymer Polymers 0.000 abstract 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract 1
- 108010039918 Polylysine Proteins 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 229920000962 poly(amidoamine) Polymers 0.000 abstract 1
- 229920000656 polylysine Polymers 0.000 abstract 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/595—Polyamides, e.g. nylon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/48—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/002—Dendritic macromolecules
- C08G83/003—Dendrimers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/16—Dendrimers and dendritic polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Nanotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyamides (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPM6239A AUPM623994A0 (en) | 1994-06-15 | 1994-06-15 | Antiviral dendrimers |
| PCT/AU1995/000350 WO1995034595A1 (en) | 1994-06-15 | 1995-06-15 | Antiviral dendrimers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9508031A true BR9508031A (pt) | 1997-09-16 |
Family
ID=3780809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9508031A BR9508031A (pt) | 1994-06-15 | 1995-06-15 | Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do composto |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6190650B1 (pt) |
| EP (1) | EP0765357B9 (pt) |
| JP (2) | JPH10501568A (pt) |
| KR (1) | KR100365028B1 (pt) |
| CN (1) | CN1134486C (pt) |
| AT (1) | ATE312866T1 (pt) |
| AU (1) | AUPM623994A0 (pt) |
| BR (1) | BR9508031A (pt) |
| CA (1) | CA2192446C (pt) |
| DE (1) | DE69534686T2 (pt) |
| DK (1) | DK0765357T3 (pt) |
| ES (1) | ES2255060T3 (pt) |
| NZ (1) | NZ287819A (pt) |
| PT (1) | PT765357E (pt) |
| WO (1) | WO1995034595A1 (pt) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2324534B (en) * | 1996-01-06 | 2000-05-10 | Danbiosyst Uk | Composition for delivery of nucleic acid to a cell |
| US5795582A (en) * | 1996-02-07 | 1998-08-18 | Novavax, Inc. | Adjuvant properties of poly (amidoamine) dendrimers |
| AUPO104496A0 (en) * | 1996-07-17 | 1996-08-08 | Biomolecular Research Institute Limited | Angiogenic inhibitory compounds |
| AUPO104396A0 (en) * | 1996-07-17 | 1996-08-08 | Biomolecular Research Institute Limited | Antiviral linear polymers |
| AU3880097A (en) | 1996-08-14 | 1998-03-06 | Warner-Lambert Company | Low molecular weight dendritic compounds as pharmaceutical agents |
| DE19726340C2 (de) * | 1996-08-16 | 1999-05-06 | Schering Ag | Zinndendrimere, ihre Verwendung als Röntgenkontrastmittel und Verfahren zu ihrer Herstellung |
| US6331296B1 (en) * | 1999-06-01 | 2001-12-18 | Stanley B. Prusiner | Food additives which affect conformationally altered proteins |
| US6720355B2 (en) * | 1997-02-21 | 2004-04-13 | The Regents Of The University Of California | Sodium dodecyl sulfate compositions for inactivating prions |
| US6719988B2 (en) | 1997-02-21 | 2004-04-13 | The Regents Of The University Of California | Antiseptic compositions for inactivating prions |
| US20060008494A1 (en) * | 1997-02-21 | 2006-01-12 | The Regents Of The University Of California | Complete inactivation of infectious proteins |
| FR2761691B1 (fr) | 1997-04-03 | 1999-05-14 | Oreal | Polymeres a fonction terminale thiol |
| FR2772771B1 (fr) * | 1997-12-19 | 2000-01-28 | Oreal | Utilisation de polymeres hyperbranches et de dendrimeres comportant un groupement particulier, en tant qu'agent filmogene, les compositions filmogenes les comprenant et leur utilisation notamment en cosmetique ou en pharmacie |
| FR2772770B1 (fr) * | 1997-12-19 | 2000-01-28 | Oreal | Nouveaux composes choisis parmi les polymeres hyperbranches et les dendrimeres ayant un groupement particulier, procede de preparation, utilisation et compositions les comprenant |
| FR2781485B1 (fr) | 1998-07-21 | 2003-08-08 | Denis Barritault | Polymeres biocompatibles leur procede de preparation et les compositions les contenant |
| US6310073B1 (en) | 1998-07-28 | 2001-10-30 | Queen's University At Kingston | Methods and compositions to treat glycosaminoglycan-associated molecular interactions |
| EP1609467A1 (en) * | 1998-07-28 | 2005-12-28 | Neurochem (International) Limited | Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions |
| US7572459B2 (en) | 1998-09-14 | 2009-08-11 | Starpharma Pty Ltd. | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
| AU767971B2 (en) * | 1998-09-14 | 2003-11-27 | Starpharma Pty Limited | Inhibition of toxic materials or substances using dendrimers |
| AU767970B2 (en) * | 1998-09-14 | 2003-11-27 | Starpharma Pty Limited | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
| AUPP584298A0 (en) * | 1998-09-14 | 1998-10-08 | Starpharma Limited | Antimicrobial and antiparasitic agents |
| US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
| SE9904289D0 (sv) * | 1999-11-26 | 1999-11-26 | Niklas Arnberg | Method and camposition for the treatment of adenovairal ocular infections |
| AUPR001000A0 (en) * | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| DE10065710A1 (de) * | 2000-12-29 | 2002-07-04 | Bayer Ag | Arzneimittel enthaltend ein Polyamin als Wirksubstanz |
| AUPR412801A0 (en) * | 2001-03-30 | 2001-05-03 | Starpharma Limited | Agent for the prevention and treatment of sexually transmitted disease s - I |
| AUPR412901A0 (en) * | 2001-03-30 | 2001-05-03 | Starpharma Limited | Agents for the prevention and treatment of sexually transmitted disease s - II |
| US20030180250A1 (en) * | 2002-03-22 | 2003-09-25 | Council Of Scientific And Industrial Research | Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents |
| AU2002249486A1 (en) * | 2002-03-26 | 2003-10-08 | Council Of Scientific And Industrial Research | Macromolecular compounds as potential anti-inflammatory agents |
| GB0209022D0 (en) * | 2002-04-19 | 2002-05-29 | Imp College Innovations Ltd | Compounds |
| EP1545462A4 (en) * | 2002-07-19 | 2007-08-08 | Univ California | DENDRIMERS AS MOLECULAR TRANSLOCATORS |
| US7001580B2 (en) * | 2002-12-31 | 2006-02-21 | 3M Innovative Properties Company | Emulsions including surface-modified organic molecules |
| JP4808610B2 (ja) * | 2003-02-13 | 2011-11-02 | ナショナル センター フォー サイエンティフィック リサーチ“デモクリトス” | 薬物および遺伝子のデリバリーシステムとしての多機能性デンドリマーおよびハイパーブランチポリマー |
| GR1004516B (el) * | 2003-02-13 | 2004-04-06 | Εθνικο Κεντρο Ερευνας Φυσικων Επιστημων (Εκεφε) - "Δημοκριτος" | Πολυ-λειτουργικα δενδριμερικα και υπερδιακλαδισμενα πολυμερη ως φορεις φαρμακων |
| US20040180852A1 (en) * | 2003-03-10 | 2004-09-16 | Cara-Lynne Schengrund | Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus |
| ES2547220T3 (es) | 2004-04-20 | 2015-10-02 | Dendritic Nanotechnologies, Inc. | Polímeros dendríticos con amplificación y funcionalidad interior mejoradas |
| US7985424B2 (en) | 2004-04-20 | 2011-07-26 | Dendritic Nanotechnologies Inc. | Dendritic polymers with enhanced amplification and interior functionality |
| DE602005012538D1 (de) * | 2004-09-21 | 2009-03-12 | Univ Lehigh | 6-200 cholansäure(derivat)-einheiten enthaltende sulfatierte molekulare schirme als anti-hiv- und anti-hsv-mittel |
| US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
| US8790672B2 (en) * | 2005-02-22 | 2014-07-29 | Nina M. Lamba-Kohli | Generation of antimicrobial surfaces using dendrimer biocides |
| EP1951266A2 (en) * | 2005-09-02 | 2008-08-06 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
| EP1924246B1 (en) | 2005-09-15 | 2015-10-21 | Genzyme Corporation | Sachet formulation for amine polymers |
| AU2006303860C1 (en) | 2005-10-18 | 2016-01-21 | Starpharma Pty Limited | Microbicidal dendrimer composition delivery system |
| WO2007045010A1 (en) * | 2005-10-21 | 2007-04-26 | Starpharma Pty Limited | Inhibitory compounds |
| DE102005056592A1 (de) * | 2005-11-25 | 2007-05-31 | Basf Ag | Herstellung und Verwendung von hochfunktionellen, hoch-oder hyperverzweigten Polylysinen |
| WO2007070801A2 (en) * | 2005-12-12 | 2007-06-21 | Allaccem, Inc. | Methods and systems for preparing antimicrobial films and coatings |
| CN101003607B (zh) * | 2006-01-16 | 2010-09-01 | 博阳生物科技（上海）有限公司 | 封闭树状大分子的方法、经封闭的树状大分子及其用途 |
| ES2937113T3 (es) * | 2006-01-20 | 2023-03-24 | Starpharma Pty Ltd | Macromolécula modificada |
| JP5322918B2 (ja) * | 2006-03-22 | 2013-10-23 | スターファーマ・プロプライエタリー・リミテッド | 避妊用組成物 |
| US20080085259A1 (en) * | 2006-05-05 | 2008-04-10 | Huval Chad C | Amine condensation polymers as phosphate sequestrants |
| AU2007275711A1 (en) * | 2006-07-18 | 2008-01-24 | Genzyme Corporation | Amine dendrimers |
| JP2010504975A (ja) | 2006-09-29 | 2010-02-18 | ゲンズイメ コーポレーション | アミドデンドリマー組成物 |
| WO2008063157A2 (en) * | 2006-10-25 | 2008-05-29 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | A nanoparticle-based anticoagulant |
| EP2120972A1 (en) | 2006-12-14 | 2009-11-25 | Genzyme Corporation | Amido-amine polymer compositions |
| WO2008103847A2 (en) | 2007-02-21 | 2008-08-28 | Allaccem, Incorporated | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
| JP2010519298A (ja) * | 2007-02-23 | 2010-06-03 | ゲンズイメ コーポレーション | アミンポリマー組成物 |
| US20100196305A1 (en) * | 2007-03-08 | 2010-08-05 | Dhal Pradeep K | Sulfone polymer compositions |
| JP2010525061A (ja) * | 2007-04-27 | 2010-07-22 | ゲンズイメ コーポレーション | アミドアミンデンドリマー組成物 |
| US20080311177A1 (en) | 2007-06-14 | 2008-12-18 | Massachusetts Institute Of Technology | Self Assembled Films for Protein and Drug Delivery Applications |
| US8188068B2 (en) * | 2007-08-10 | 2012-05-29 | Allaccem, Inc. | Bridged polycyclic compound based compositions for coating oral surfaces in pets |
| US8153618B2 (en) * | 2007-08-10 | 2012-04-10 | Allaccem, Inc. | Bridged polycyclic compound based compositions for topical applications for pets |
| US8153617B2 (en) * | 2007-08-10 | 2012-04-10 | Allaccem, Inc. | Bridged polycyclic compound based compositions for coating oral surfaces in humans |
| US20090074833A1 (en) * | 2007-08-17 | 2009-03-19 | Whiteford Jeffery A | Bridged polycyclic compound based compositions for controlling bone resorption |
| EP2217215A1 (en) * | 2007-12-14 | 2010-08-18 | Genzyme Corporation | Coated pharmaceutical compositions |
| WO2009154747A1 (en) * | 2008-06-20 | 2009-12-23 | Genzyme Corporation | Pharmaceutical compositions |
| US20100016270A1 (en) * | 2008-06-20 | 2010-01-21 | Whiteford Jeffery A | Bridged polycyclic compound based compositions for controlling cholesterol levels |
| US20100004218A1 (en) * | 2008-06-20 | 2010-01-07 | Whiteford Jeffery A | Bridged polycyclic compound based compositions for renal therapy |
| US9198875B2 (en) | 2008-08-17 | 2015-12-01 | Massachusetts Institute Of Technology | Controlled delivery of bioactive agents from decomposable films |
| WO2011036560A2 (en) | 2009-09-23 | 2011-03-31 | Novartis Ag | Glycoconjugate compositions and methods for treatment of hiv |
| IL229439A (en) * | 2011-05-16 | 2017-09-28 | Starpharma Pty Ltd | Macromolecules for treatment or prophylaxis of bacterial vaginosis |
| AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
| EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
| US9347065B2 (en) | 2012-03-29 | 2016-05-24 | International Aids Vaccine Initiative | Methods to improve vector expression and genetic stability |
| WO2013163234A1 (en) | 2012-04-23 | 2013-10-31 | Massachusetts Institute Of Technology | Stable layer-by-layer coated particles |
| CN108452316B (zh) * | 2012-09-13 | 2022-04-15 | 星法马有限公司 | 眼部感染的治疗或预防方法 |
| WO2014134029A1 (en) | 2013-02-26 | 2014-09-04 | Massachusetts Institute Of Technology | Nucleic acid particles, methods and use thereof |
| WO2014150074A1 (en) | 2013-03-15 | 2014-09-25 | Massachusetts Institute Of Technology | Compositions and methods for nucleic acid delivery |
| EP2987503A1 (en) * | 2014-08-22 | 2016-02-24 | Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | Methods and reagents for prevention and/or treatment of infection |
| US10479868B2 (en) | 2014-09-04 | 2019-11-19 | Nano Precision Medical, Inc. | Polymeric stabilizing formulations |
| US12071516B2 (en) | 2014-09-04 | 2024-08-27 | Nano Precision Medical, Inc. | Polymeric stabilizing formulations |
| US10154956B2 (en) * | 2015-07-28 | 2018-12-18 | Carnegie Mellon University | Methods and compounds to suppress viral genome release and packaging |
| US10702572B2 (en) | 2015-07-28 | 2020-07-07 | Carnegie Mellon University | Methods and compounds to suppress viral genome release and packaging |
| BR112018072741A2 (pt) * | 2016-05-05 | 2019-02-19 | Starpharma Pty Ltd | método para a profilaxia de infecção pelo vírus da zika |
| WO2019089567A1 (en) | 2017-10-30 | 2019-05-09 | Massachusetts Institute Of Technology | Layer-by-layer nanoparticles for cytokine therapy in cancer treatment |
| US12018315B2 (en) | 2019-05-30 | 2024-06-25 | Massachusetts Institute Of Technology | Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids |
| US11028264B2 (en) | 2019-08-05 | 2021-06-08 | International Business Machines Corporation | Polylysine polymers with antimicrobial and/or anticancer activity |
| DE112020002996T5 (de) * | 2019-08-05 | 2022-05-19 | Agency For Science, Technology And Research | Polylysin-Polymere mit antimikrobieller und/oder krebsbekämpfender Aktivität |
| GB202312563D0 (en) * | 2020-04-15 | 2023-10-04 | Starpharma Pty Ltd | Method of prophylaxis of coronavirus and/or respiratory syncytial virus |
| GB202007701D0 (en) | 2020-05-22 | 2020-07-08 | Univ Manchester | Antiviral polymers |
| CN114053392B (zh) * | 2020-07-30 | 2024-06-21 | 广州朗圣药业有限公司 | 新型化合物在制备预防和/或治疗hpv感染的药物中的应用 |
| CN114053394B (zh) * | 2020-07-30 | 2024-06-21 | 广州朗圣药业有限公司 | 新型化合物在制备预防和/或治疗冠状病毒感染的药物中的应用 |
| US20220040315A1 (en) | 2020-08-09 | 2022-02-10 | Fulu Labs Corporation | Nuclease-dendrimer formulations for covid-19 and broad-spectrum antiviral therapy and prophylaxis |
| WO2022040761A1 (en) * | 2020-08-31 | 2022-03-03 | Starpharma Pty Ltd | Dendrimer-drug conjugate |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4410688A (en) * | 1981-04-29 | 1983-10-18 | Allied Corporation | Macromolecular highly branched homogeneous compound |
| US4507466A (en) * | 1983-01-07 | 1985-03-26 | The Dow Chemical Corporation | Dense star polymers having core, core branches, terminal groups |
| US4599400A (en) * | 1984-12-18 | 1986-07-08 | The Dow Chemical Company | Star/comb-branched polyamide |
| ATE89743T1 (de) * | 1986-08-18 | 1993-06-15 | Dow Chemical Co | Conjugate dichter sterne. |
| US5229490A (en) | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
| CA1341285C (en) * | 1988-02-12 | 2001-08-14 | Chang Yi Wang | Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
| EP0339695A3 (en) | 1988-04-29 | 1990-05-30 | Stichting Voor De Technische Wetenschappen | A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates |
| JPH03236366A (ja) * | 1989-12-22 | 1991-10-22 | Banyu Pharmaceut Co Ltd | グアニジノベンゼン誘導体 |
| US5312837A (en) * | 1991-01-29 | 1994-05-17 | Genelabs Technologies, Inc. | Method of treating viral infections with aryl macrocyclic compounds |
| NL9100434A (nl) * | 1991-03-11 | 1992-10-01 | Rijksuniversiteit | Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan. |
| WO1993003766A1 (en) * | 1991-08-13 | 1993-03-04 | Repligen Corporation | Multiple antigen peptides for use as hiv vaccines |
| ZA928396B (en) * | 1991-11-01 | 1993-05-12 | Smithkline Beecham Corp | HIV protease inhibitors. |
| AU681735C (en) * | 1993-07-14 | 2002-02-21 | Regents Of The University Of California, The | Self-assembling polynucleotide delivery system comprising dendrimer polycations |
-
1994
- 1994-06-15 AU AUPM6239A patent/AUPM623994A0/en not_active Abandoned
-
1995
- 1995-06-15 DE DE69534686T patent/DE69534686T2/de not_active Expired - Lifetime
- 1995-06-15 AT AT95921661T patent/ATE312866T1/de active
- 1995-06-15 PT PT95921661T patent/PT765357E/pt unknown
- 1995-06-15 BR BR9508031A patent/BR9508031A/pt not_active IP Right Cessation
- 1995-06-15 EP EP95921661A patent/EP0765357B9/en not_active Expired - Lifetime
- 1995-06-15 ES ES95921661T patent/ES2255060T3/es not_active Expired - Lifetime
- 1995-06-15 US US08/765,528 patent/US6190650B1/en not_active Expired - Lifetime
- 1995-06-15 CA CA002192446A patent/CA2192446C/en not_active Expired - Lifetime
- 1995-06-15 DK DK95921661T patent/DK0765357T3/da active
- 1995-06-15 WO PCT/AU1995/000350 patent/WO1995034595A1/en not_active Ceased
- 1995-06-15 CN CNB951941453A patent/CN1134486C/zh not_active Expired - Lifetime
- 1995-06-15 KR KR1019960707144A patent/KR100365028B1/ko not_active Expired - Fee Related
- 1995-06-15 NZ NZ287819A patent/NZ287819A/en not_active IP Right Cessation
- 1995-06-15 JP JP8501397A patent/JPH10501568A/ja not_active Withdrawn
-
2005
- 2005-09-15 JP JP2005268847A patent/JP4589851B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10501568A (ja) | 1998-02-10 |
| AUPM623994A0 (en) | 1994-07-07 |
| WO1995034595A1 (en) | 1995-12-21 |
| EP0765357B1 (en) | 2005-12-14 |
| EP0765357B9 (en) | 2006-08-16 |
| EP0765357B8 (en) | 2006-03-08 |
| NZ287819A (en) | 1998-06-26 |
| DE69534686D1 (de) | 2006-01-19 |
| ES2255060T3 (es) | 2006-06-16 |
| DK0765357T3 (da) | 2006-07-17 |
| KR100365028B1 (ko) | 2003-05-12 |
| CA2192446C (en) | 2004-08-31 |
| HK1002899A1 (en) | 1998-09-25 |
| EP0765357A4 (en) | 1997-07-30 |
| PT765357E (pt) | 2006-05-31 |
| CN1134486C (zh) | 2004-01-14 |
| CN1154123A (zh) | 1997-07-09 |
| US6190650B1 (en) | 2001-02-20 |
| EP0765357A1 (en) | 1997-04-02 |
| JP4589851B2 (ja) | 2010-12-01 |
| CA2192446A1 (en) | 1995-12-21 |
| ATE312866T1 (de) | 2005-12-15 |
| DE69534686T2 (de) | 2006-09-21 |
| JP2006070036A (ja) | 2006-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9508031A (pt) | Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do composto | |
| MX9203653A (es) | Composiciones amfotericas y formas polimericas de los alfa-hidroxiacidos. | |
| DE69903351D1 (de) | Vernetzte hyaluronsäure und ihre medizinischen verwendungen | |
| BR9710375A (pt) | Processo e composi-Æo farmac-utica ou veterin ria para a inibi-Æo profil tica ou terap-utica da angiog-nese em um ser humano ou animal nÆo humano uso de um pol¡mero ou dendr¡mero tendo uma pluralidade de grupos terminais | |
| BR9814680A (pt) | Gels superabsorventes com base em poli (vinilamina), e método para manufaturar o mesmo | |
| DK1181323T3 (da) | Biomaterialer dannet med nukleofil additionsreaktion med konjugerede uimættede grupper | |
| DE69333607D1 (de) | Vorrichtung zur Herstellung von vorgefüllten, sterilen Abgabevorrichtungen | |
| ES2151599T3 (es) | Acidos hidroxamicos substituidos con arilsulfonamido como inhibidores de matriz metaloproteinasas. | |
| AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
| FI970810A0 (fi) | Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja | |
| ATE541587T1 (de) | Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen | |
| BR0107942A (pt) | Polìmeros de proteìna de liberação lenta | |
| BR9912376A (pt) | Sais de nitrato, composições farmacêuticas, udo de sais e composições, e, processo para preparação de sais de nitrato. | |
| ATE295837T1 (de) | Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen | |
| BR9913718A (pt) | Processo e composição farmacêutica ou veterinária para inibição profilática ou terapêutica de um material ou substância tóxica em um paciente animal humano ou não-humano, e, uso de um dendrìmero aniÈnico ou catiÈnico | |
| DK0841931T3 (da) | Farmaceutisk sammensætning | |
| NO20031650D0 (no) | Nye legemidler for leversykdommer | |
| DE60003074D1 (de) | Fusidinsäure-derivate | |
| BR9903003A (pt) | Processo para preparação de ácidos quinolono e naftiridono carboxìlicos | |
| DK0793691T3 (da) | Bitumenkompositioner | |
| BR9901387A (pt) | Composições para a cura de polìmero. | |
| BR9901390A (pt) | Composições para a cura de polìmero | |
| ES1023376Y (es) | Tarjeta perfeccionada para la memorizacion de codigos. | |
| IT1269735B (it) | Prodotti provvisti di un gruppo nitroestere terminale dotati di attivita' anti-infiammatoria e/o analgesica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
| HJEG | Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law | ||
| FF | Decision: intention to grant | ||
| FG9A | Patent or certificate of addition granted | ||
| B25A | Requested transfer of rights approved |
Owner name: STARPHARMA PTY LTD. (AU) Free format text: TRANSFERIDO DE: BIOMOLECULAR RESEARCH INSTITUTE LTD. |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 15/06/2015 |